中国生命集团有限公司（08296）于2026年3月3日发布2026年2月股份变动月报表。报告期为2026年2月1日至2026年2月28日，公告显示公司股本及股份结构未发生实质变化。
公司注册股本维持为10亿股，每股面值1港元；截至2月底已发行股份总数为9,450万股，与上月末持平。未有新增发行、购回或注销；公司亦无库藏股记录。购股权计划方面，仍有约185.32万份购股权未行使，较上月无变化。另有可换股债券余额1,816万港元，转换价为每股1.26港元，报告期内并无转股新增发行。
根据公告，截至2月底公众持股量符合相关上市规则的最低要求。公司声明已遵守香港联交所《上市规则》及相关法律法规的规定。该月报表由公司秘书朱健明签署。公司股本维持稳定，未见任何影响股本结构的活动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.